KLP Kapitalforvaltning AS Takes Position in Maximus, Inc. (NYSE:MMS)

KLP Kapitalforvaltning AS acquired a new stake in Maximus, Inc. (NYSE:MMS - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund acquired 24,400 shares of the health services provider's stock, valued at approximately $1,821,000.

Other hedge funds have also bought and sold shares of the company. Geode Capital Management LLC lifted its holdings in shares of Maximus by 1.4% in the third quarter. Geode Capital Management LLC now owns 1,525,159 shares of the health services provider's stock worth $142,109,000 after buying an additional 21,532 shares in the last quarter. Van Berkom & Associates Inc. raised its position in Maximus by 8.5% in the 4th quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock worth $93,792,000 after purchasing an additional 98,264 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in Maximus by 7.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider's stock worth $74,700,000 after purchasing an additional 71,598 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its position in Maximus by 2.4% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 722,172 shares of the health services provider's stock valued at $54,748,000 after buying an additional 16,772 shares during the period. Finally, Bank of New York Mellon Corp grew its stake in shares of Maximus by 8.2% during the fourth quarter. Bank of New York Mellon Corp now owns 570,740 shares of the health services provider's stock valued at $42,606,000 after buying an additional 43,421 shares during the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Maximus Trading Up 0.7 %

NYSE MMS traded up $0.45 on Tuesday, hitting $68.64. The company's stock had a trading volume of 547,975 shares, compared to its average volume of 533,810. The company's 50-day simple moving average is $69.57 and its 200 day simple moving average is $77.51. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97. The firm has a market cap of $3.88 billion, a P/E ratio of 14.76 and a beta of 0.71. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Research analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 1.75%. Maximus's payout ratio is 25.81%.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on MMS. StockNews.com downgraded Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target on the stock in a report on Thursday, January 2nd.

Insiders Place Their Bets

In other news, insider Ilene R. Baylinson sold 14,500 shares of the firm's stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. This trade represents a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.